Drug
Glimepiride clinical trials
Also written Amaryl.
- studies test it
- 77
- open now
- 2
- in phase 3
- 21
- first study started
- 2000
Keep track of what changes. Save the glimepiride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
77 studies that test it; most in 2003 (8)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 8 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 5 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 15
- Phase 2
- 3
- Phase 3
- 21
- Phase 4
- 29
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 50 · Other 27
Sanofi (11) · AstraZeneca (4) · Novo Nordisk A/S (4) · Takeda (4) · Handok Inc. (3) · Laboratorios Silanes S.A. de C.V. (2) · Teva Pharmaceuticals USA (2) · Mylan Pharmaceuticals Inc (2)
Often tested with
Tested in the same studies.
Metformin (23) · Sitagliptin (8) · Insulin Glargine (5) · Dapagliflozin (5) · Vildagliptin (4) · Saxagliptin (4) · Liraglutide (4) · Pioglitazone (4)
Studies
Open first, then newest update. How each study uses glimepiride is read from its arms, and is right about nine times in ten.
Testing it · 77
- Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3RecruitingNot applicableWashington University School of MedicineNCT07589387Written as Glimepiride
- Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.Not yet recruitingPhase 3Tongji HospitalNCT07288749Written as Glimepiride (oral)
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedPhase 3GRADE Study GroupNCT01794143Written as Sulfonylurea (glimepiride)
- Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment FailureCompletedPhase 3Laboratorios Silanes S.A. de C.V.NCT04841096Written as (A2) Glimepiride/Vildagliptin/Metformin
- A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With AlbuminuriaTerminatedPhase 4Astellas Pharma Korea, Inc.NCT03118713Written as glimepiride
- Glimepiride 4 mg Tablets Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00835172Written as Glimepiride 4 mg Tablets
- Glimepiride 4 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00834340Written as Glimepiride 4 mg Tablets
- Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648362Written as Glimepiride Tablets 1 mg
- Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00650533Written as Glimepiride Tablets 1 mg
- Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy SubjectsCompletedNot applicablePT Harsen LaboratoriesNCT05468879Written as Glimepiride
- The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency DiabetesStatus unknownPhase 4Peking University People's HospitalNCT05386186Written as Glimepiride
- Fenofibrate Versus Curcumin in Type 2 Diabetic PatientsCompletedPhase 4Rehab WeridaNCT04528212Written as Glimepiride Tablets
- Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinCompletedPhase 1TheracosNCT02956044Written as Glimepiride
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDCompletedPhase 4Kanazawa UniversityNCT02649465Written as Glimepiride
- Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedPhase 3TheracosNCT02769481Written as Glimepiride
- Risk Reduction in Coronary Heart DiseaseCompletedNot applicableSorlandet Hospital HFNCT00679237Written as metformin, glimepiride, insulin
- Glimepiride, Alogliptin and Alogliptin+Pioglitazone CombinationStatus unknownPhase 4Seoul National University HospitalNCT04470310Written as Glimepiride
- A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCompletedPhase 3AstraZenecaNCT02419612Written as Glimepiride
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownPhase 4Peking Union Medical College HospitalNCT04287387Written as Glimepiride Tablets
- Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During RamadanCompletedPhase 4University of JordanNCT04237493Written as Metformin and Glimepiride (Low Dosage)
See all 77 studies that test glimepiride →
Given in every arm · 33 — glimepiride is usual care beside what is tested
- Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CADCompletedPhase 4Damanhour UniversityNCT03693560Written as Glimepiride upto 4 mg Oral Tablet
- Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyCompletedPhase 4Seoul National University Bundang HospitalNCT02338921Written as Glimepirde
- Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)CompletedPhase 4University of MichiganNCT02973477Written as Glimepiride
- A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)CompletedPhase 3Merck Sharp & Dohme LLCNCT02630706Written as Glimepiride
- Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)CompletedPhase 3Merck Sharp & Dohme LLCNCT02226003Written as Glimepiride
- Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)CompletedPhase 3Merck Sharp & Dohme LLCNCT02036515Written as Glimepiride
- Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)CompletedPhase 3Merck Sharp & Dohme LLCNCT02099110Written as Glimepiride Rescue Medication
- A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)CompletedPhase 3Merck Sharp & Dohme LLCNCT01717313Written as Glimepiride
- Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)CompletedPhase 3Merck Sharp & Dohme LLCNCT01704261Written as Glimepiride
- Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)CompletedPhase 3Merck Sharp & Dohme LLCNCT01841697Written as Open-label Glimepiride
- Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00427154Written as glimepiride
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)TerminatedPhase 3Merck Sharp & Dohme LLCNCT01678820Written as Glimepiride
- A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)CompletedPhase 3Merck Sharp & Dohme LLCNCT01590771Written as Glimepiride
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)CompletedPhase 3Merck Sharp & Dohme LLCNCT01177384Written as Glimepiride
- A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)TerminatedPhase 3Merck Sharp & Dohme LLCNCT01477853Written as Glimepiride (open-label)
- A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)CompletedPhase 3Merck Sharp & Dohme LLCNCT01958671Written as Glimepiride
- DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)WithdrawnPhase 3Diabetes Frail LtdNCT02484209Written as Glimepiride
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)CompletedPhase 3Merck Sharp & Dohme LLCNCT01296412Written as glimepiride
- Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00343980Written as glimepiride
- Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentCompletedPhase 4Novo Nordisk A/SNCT01123980Written as glimepiride
Showing 20 of 33.
As the comparator · 77 — what is tested is compared with glimepiride
- Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus PatientsNot yet recruitingPhase 4Chong Kun Dang PharmaceuticalNCT07365358Written as Glimepiride 1mg
- Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 DiabetesRecruitingPhase 4Yonsei UniversityNCT05975528Written as Glimepiride
- Vildagliptin Versus Glimepiride in Type 2 Diabetic PatientsCompletedNot applicableDamanhour UniversityNCT06068686Written as Glimepiride 3 Mg Oral Tablet
- Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNot applicableUniversity of Colorado, DenverNCT01951339Written as Glimepiride
- Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 DiabetesStatus unknownPhase 4Seoul National University Bundang HospitalNCT05663736Written as Glimepiride
- Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)CompletedPhase 4University of CatanzaroNCT04183868Written as Glimepiride 2 mg
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell MassCompletedNot applicableUniversity of PennsylvaniaNCT00775684Written as Glimepiride
- Initial Combination of Gemigliptin and Metformin on Microbiota ChangeCompletedNot applicableSeoul National University Bundang HospitalNCT02609815Written as glimepiride/metformin
- Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin MonotherapyCompletedPhase 3Lexicon PharmaceuticalsNCT03332771Written as Glimepiride
- Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesCompletedPhase 3Novartis PharmaceuticalsNCT00106340Written as glimepiride
- Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 DiabetesCompletedNot applicableYonsei UniversityNCT02964572Written as Glimepiride
- Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During RamadanCompletedPhase 4University of LeicesterNCT02694263Written as Glimepiride
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesCompletedPhase 3Boehringer IngelheimNCT01243424Written as glimepiride
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedPhase 4Eli Lilly and CompanyNCT02072096Written as Glimepiride
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT01644500Written as Glimepiride
- Foxiga Korea Local Phase 4 StudyCompletedPhase 4AstraZenecaNCT02564926Written as Glimepiride
- Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 DiabetesCompletedPhase 4Kansai Electric Power HospitalNCT02312063Written as Glimepiride
- SGLT2 Inhibition and Left Ventricular MassTerminatedPhase 4Hannover Medical SchoolNCT02728453Written as Glimepiride
- Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 DiabetesTerminatedPhase 4GWT-TUD GmbHNCT02373865Written as Glimepiride
- Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular EdemaTerminatedPhase 4Hannover Medical SchoolNCT02985242Written as Glimepiride
Showing 20 of 77.
Codes
What other systems call glimepiride · ClinicalTrials.gg INT003395
- MeSH (NLM) C057619glimepirideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6KY687524KGLIMEPIRIDEConfirmed FDA, NLM, Wikidata
- RxNorm 25789Confirmed FDA, Wikidata
- Wikidata Q106029845glimepirideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29073GlimepirideOne source FDA
- DrugBank DB00222One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C057619 | glimepiride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6KY687524K | GLIMEPIRIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 25789 | — | Confirmed FDA, Wikidata |
| Wikidata | Q106029845 | glimepiride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29073 | Glimepiride | One source FDA |
| DrugBank | DB00222 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.